title: Folic acid-modified mesoporous silica nanoparticles for cellular and nuclear targeted drug delivery.
authors.affiliation: Leiden Institute of Chemistry, Leiden University, Leiden, The Netherlands.
authors.forename: Fabiola
authors.initials: F
authors.lastname: Porta
authors.forename: Gerda E M
authors.initials: GE
authors.lastname: Lamers
authors.forename: Jess
authors.initials: J
authors.lastname: Morrhayim
authors.forename: Antonia
authors.initials: A
authors.lastname: Chatzopoulou
authors.forename: Marcel
authors.initials: M
authors.lastname: Schaaf
authors.forename: Hans
authors.initials: H
authors.lastname: den Dulk
authors.forename: Claude
authors.initials: C
authors.lastname: Backendorf
authors.forename: Jeffrey I
authors.initials: JI
authors.lastname: Zink
authors.forename: Alexander
authors.initials: A
authors.lastname: Kros
mesh_terms: D000970:Antineoplastic Agents / Q000008:administration & dosage*; D015153:Blotting, Western; D002166:Camptothecin / Q000008:administration & dosage*; D045744:Cell Line, Tumor; D004337:Drug Carriers / Q000737:chemistry; D005492:Folic Acid; D006801:Humans; D020287:In Situ Nick-End Labeling; D018613:Microscopy, Confocal; D053758:Nanoparticles; D012822:Silicon Dioxide
chemical_list: D000970:Antineoplastic Agents; D004337:Drug Carriers; D012822:Silicon Dioxide; D005492:Folic Acid; D002166:Camptothecin